Dr. Ceferino S. Rodolfo, DTI Undersecretary and BOI Vice Chairman and Managing Head, identified the November 18 and November 20, 2026 submission letters. They accompanied CALE88 Foods Corporation’s registration, operations, incentive and ownership records, with the supplementary letter listing eighteen application and internal approval records.
Research record
November 20, 2026
Related BOI, FDA and corporate records discussed during the November 20, 2026 sitting, grouped by subject.
Related Documents
Read and verify
An exact document is linked only when a public or privacy-cleared copy is available. Specifically identified unavailable documents remain listed without a substitute download. Transcript citations remain with each record.
BOI submissions to the impeachment court
BOI correspondence
Not available in the Senate document archive.BOI registration and start-of-operations records
Registration and project records
Not available in the Senate document archive.The records include the December 9, 2021 approval letter and Certificate of Registration No. 2021-186, the specific and general registration conditions, the December 3, 2021 plant-visit report and photographs, and the report of the January 1, 2023 commercial start. Dr. Ceferino S. Rodolfo, DTI Undersecretary and BOI Vice Chairman and Managing Head, explained the registered banana-chip export project; cross-examination addressed the commercial-start report’s 2024 notarization and filing deadline.
Annual operations reports and financial statements, 2023–2025
Company reporting to BOI
Not available in the Senate document archive.CALE88 Foods Corporation’s Form S-1 annual operations reports and audited financial statements for 2023, 2024 and 2025 were examined together. Dr. Ceferino S. Rodolfo, DTI Undersecretary and BOI Vice Chairman and Managing Head, described BOI’s comparison of the reports. Questioning covered employee counts, export sales, the amended 2024 return and a 2024 heading on the return he identified as covering 2025.
VAT zero-rating and tax-incentive records
BOI incentive certifications and supporting records
Not available in the Senate document archive.The group comprises the May 2, 2024 and April 10, 2026 VAT zero-rate certifications and their supporting affidavits, bank records and export-sales reports, together with the April 22, 2025 Certificate of Entitlement to Tax Incentives. Dr. Ceferino S. Rodolfo, DTI Undersecretary and BOI Vice Chairman and Managing Head, explained the certifications. Defense counsel Atty. Justin Nicol B. Gular asked that the bank documents supporting the 2026 certification not be displayed to protect privacy.
Good-standing request and 2026 inspection
BOI compliance inspection and correspondence
Not available in the Senate document archive.The records trace the April 29, 2026 request for good-standing certification for Customs accreditation, the April 28 travel order, the May 18 site-inspection report and photographs, and the June 16 endorsement of good standing. Dr. Ceferino S. Rodolfo, DTI Undersecretary and BOI Vice Chairman and Managing Head, discussed the labor commitment, reduced employment, management and ownership changes, and documentary compliance.
Ownership correspondence and General Information Sheets
BOI correspondence and SEC corporate filings
The group includes the July 8, 2026 ownership-change request, BOI’s response and the 2024 and 2025 General Information Sheets discussed in court. Dr. Ceferino S. Rodolfo, DTI Undersecretary and BOI Vice Chairman and Managing Head, said BOI noted the change and updated its records. Counsel identified the response date as October 29 on direct examination and October 9 on cross-examination. Sen. Vicente C. Sotto III raised differences between BOI and SEC copies; Rodolfo said both agencies should receive the same information. The links open the separate SEC filings for those years.
FDA banana-chip applications, labels and registrations
FDA product and establishment records
Not available in the Senate document archive.The FDA records cover the February 24, 2022 denial, March 29 Intertech test report, April 30 reapplication with former and revised labels, June 15 local-market product registration, July 2 export application and generic-box photographs, August 17 export-market product registration, and supporting licenses to operate. Pilar Marilyn M. Pagayunan, Director IV of the FDA Center for Food Regulation and Research, explained the labeling corrections and nutrition-analysis support. Examination distinguished the renewed license attached from FDA’s system from the earlier license supporting the original application.
Forensic report of Atty. Alexander B. Cabrera
Expert financial report
Not available in the Senate document archive.Defense counsel Atty. Justin Nicol B. Gular cited prosecution forensic witness Atty. Alexander B. Cabrera’s report, including page 36 and Table 39, when contesting its description of CALE88 Foods Corporation’s business model and account of money received by shareholder Atty. Manases R. Carpio.
Articles of Impeachment — Article II
Articles of Impeachment
Defense counsel Atty. Justin Nicol B. Gular offered the BOI and FDA testimony to rebut the Article II allegations and the prosecution forensic account of CALE88 Foods Corporation.